Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri Lanka

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  Kularatna, Sanjeewa ^a   Whitty, Jennifer A ^a   Johnson, Newell W ^a   Scuffham, Paul A ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

EORTC 8D; EQ 5D; Health state valuation; Low and middle income countries; QALY; Time trade off; Utilities

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CLUSTER ANALYSIS; DEMOGRAPHY; DEPENDENT VARIABLE; HEALTH CARE UTILIZATION; HEALTH STATUS; HOUSEHOLD; HUMAN; INCOME; INDEPENDENT VARIABLE; INTERVIEW; POPULATION RESEARCH; RANDOMIZATION; RELIABILITY; SAMPLING; SELF CARE; SRI LANKA; VALIDITY;

ADOLESCENT; ADULT; HEALTH STATUS; HUMANS; MIDDLE AGED; PSYCHOMETRICS; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESOURCE ALLOCATION; SRI LANKA; YOUNG ADULT;

EID: 84883147278     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-149     Document Type: Article

References (52)

1. Drummond MF. Methods for the economic evaluation of healthcare programmes 1999, Oxfrord: Oxfrord Medical Publications.
2. NICE Technical guidance for manufacturers and sponsors onmaking a submission to a technology appraisal 2001, London: NICE, NICE.
3. Ministry of Health Ontario guidelines for economic analysis of pharmaceutical products 1994, Toronto: Ministry of Health, Ministry of Health.
4. Commitee PBA Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (version 4.3) 2008, Canberra, Australia: Department of Health and Ageing, Commitee PBA.
5. The EuroQol Group EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16(3):199-208. Epub 1990/11/05, The EuroQol Group.
6. Norman R, Cronin P, Viney R. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl Health Econ Health Policy 2013, 11(3):287-298. Epub 2013/05/08, 10.1007/s40258-013-0035-z, 23649892.
7. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21(2):271-292. Epub 2002/04/10, 10.1016/S0167-6296(01)00130-8, 11939242.
8. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care 1996, 34(7):702-722. 10.1097/00005650-199607000-00004, 8676608.
9. AQoL Assessment of quality of life 2011, [cited 2011 15.10.2011]; Available from: http://www.aqol.com.au/index.php/aqolinstruments, AQoL.
10. Bansback N, Brazier J, Tsuchiya A, Anis A. Using a discrete choice experiment to estimate health state utility values. J Health Econ 2012, 31(1):306-318. 10.1016/j.jhealeco.2011.11.004, 22197308.
11. WorldBank accessed August 2012. http://data.worldbank.org/about/country-classifications/country-and-lending-groups, WorldBank.
12. World Health Organization World health statistics 2011, Geneva, Switzerland: WHO Press, World Health Organization.
13. Norman R, Cronin P, Viney R, King M, Street D, Ratcliffe J. International comparisons in valuing EQ-5D health states: a review and analysis. Value Health 2009, 12(8):1194-1200. Epub 2009/08/22, 10.1111/j.1524-4733.2009.00581.x, 19695009.
14. Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 2001, 21(1):7-16. Epub 2001/02/24, 10.1177/0272989X0102100102, 11206949.
15. Kularatna S, Whitty JA, Johnson NW, Scuffham PA. Health state valuation in low and middle income countries: a systematic review of the literature. Value Health 2013, In press.
16. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223. Epub 2012/12/19, 10.1016/S0140-6736(12)61689-4, 23245608.
17. Bailey H, Kind P. Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets. Qual Life Res 2010, 19(8):1145-1154. 10.1007/s11136-010-9678-5, 20496167.
18. Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT, et al. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health 2011, 14(5):721-731. Epub 2011/08/16, 10.1016/j.jval.2011.01.004, 21839411.
19. Ministry of Health Annual health statistics 2007, Colombo, Sri Lanka, Ministry of Health.
20. Viney R, Norman R, King MT, Cronin P, Street DJ, Knox S, et al. Time trade-off derived EQ-5D weights for Australia. Value Health 2011, 14(6):928-936. Epub 2011/09/15, 10.1016/j.jval.2011.04.009, 21914515.
21. Buxton MJ. Economic evaluation and decision making in the UK. Pharmacoeconomics 2006, 24(11):1133-1142. Epub 2006/10/28, 10.2165/00019053-200624110-00009, 17067197.
22. Cleemput I. A social preference valuations set for EQ-5D health states in Flanders Belgium. Eur J Health Econ 2010, 11(2):205-213. Epub 2009/07/08, 10.1007/s10198-009-0167-0, 19582490.
23. Dolan P, Gudex C, Kind P, William A. Valuing health states: a comparison of methods, HESG Conference, Strathclyde 1993,
24. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis 1987, 40(6):593-603. 10.1016/0021-9681(87)90019-1, 3298297.
25. Viney R, Norman R, Brazier J, Cronin P, King MT, Ratcliffe J, et al. An Australian discrete choice experiment to value Eq-5d health states. Health Econ 2013, Epub 2013/06/15.
26. Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 2005, 6(2):124-130. Epub 2005/06/01, 10.1007/s10198-004-0264-z, 19787848.
27. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 2005, 43(3):203-220. 10.1097/00005650-200503000-00003, 15725977.
28. Tsuchiya A, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ 2002, 11(4):341-353. 10.1002/hec.673, 12007165.
29. Augustovski FA, Irazola VE, Velazquez AP, Gibbons L, Craig BM. Argentine valuation of the EQ-5D health states. Value Health 2009, 12(4):587-596. 10.1111/j.1524-4733.2008.00468.x, 19900257.
30. Zarate V, Kind P, Valenzuela P, Vignau A, Olivares-Tirado P, Munoz A. Social valuation of EQ-5D health states: the Chilean case. Value Health 2011, 14(8):1135-1141. 10.1016/j.jval.2011.09.002, 22152184.
31. Tongsiri S, Cairns J. Estimating population-based values for EQ-5D health states in Thailand. Value Health 2011, 14(8):1142-1145. 10.1016/j.jval.2011.06.005, 22152185.
32. Jelsma J, Hansen K, De Weerdt W, De Cock P, Kind P. How do Zimbabweans value health states?. Popul Health Metr 2003, 1(1):11. Epub 2003/12/18, 10.1186/1478-7954-1-11, 317383, 14678566.
33. Arnesen T, Trommald M. Are QALYs based on time trade-off comparable?-a systematic review of TTO methodologies. Health Econ 2005, 14(1):39-53. 10.1002/hec.895, 15386674.
34. Augestad LA, Rand-Hendriksen K, Kristiansen IS, Stavem K. Learning effects in time trade-off based valuation of EQ-5D health states. Value Health 2012, 15(2):340-345. 10.1016/j.jval.2011.10.010, 22433766.
35. Tilling C, Devlin N, Tsuchiya A, Buckingham K. Protocols for time tradeoff valuations of health states worse than dead: a literature review. Med Decis Making 2010, 30(5):610-619. Epub 2010/01/14, 10.1177/0272989X09357475, 20068144.
36. Norman R, King MT, Clarke D, Viney R, Cronin P, Street D. Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task. Qual Life Res 2010, 19(4):499-508. Epub 2010/02/23, 10.1007/s11136-010-9609-5, 20174998.
37. Kharroubi SA, O'Hagan A, Brazier JE. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method. Stat Med 2010, 29(15):1622-1634. Epub 2010/03/09.
38. Lamers LM. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets. Med Care 2007, 45(3):238-244. 10.1097/01.mlr.0000252166.76255.68, 17304081.
39. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ 1996, 5(2):141-154. Epub 1996/03/01, 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO;2-N, 8733106.
40. Gudex C. Time trade off user manual:props and self completion methods 1994, York: The University of York.
41. Gudex C, Dolan PH, Kind P, Thomas R, Williams AH. Valuing health states. Eur J Public Health 1997, 7(4):441-448.
42. Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007, 5:70. Epub 2007/12/25, 10.1186/1477-7525-5-70, 2248572, 18154669.
43. Lwanga SK, Lemeshow S. Sample size determination in health studies. A practical manual 1991, Geneva: World Health Organization.
44. Scheaffer R. Elemantary survey sampling 1979, Boston: PWS-KENT.
45. Bennett S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster-sample surveys of health in developing countries. World Health Stat Q 1991, 44(3):98-106.
46. Perera IR, Usgodaarachchi US. Development of a psychometric scale to assess satisfaction with dental care among Sri Lankans. Community Dent Health 2009, 26(3):150-156. Epub 2009/09/29.
47. Kish L. A procedure for objective respondent selection within the household. J Am Stat Assoc 1949, 44(247):380-387.
48. Jayasekara H, Rajapaksa L, Bredart A. Psychometric evaluation of the European Organization for Research and Treatment of Cancer in-patient satisfaction with care questionnaire ('Sinhala' version) for use in a South-Asian setting. Int J Qual Health Care 2008, 20(3):221-226. Epub 2008/03/15, 10.1093/intqhc/mzn006, 18339668.
49. Dolan PD. Modeling valuations for EuroQol health states. Med Care 1997, 35(11):1095-1108. 10.1097/00005650-199711000-00002, 9366889.
50. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974, 19(6):716-723.
51. Schwarz G. Estimating the dimension of a model. Ann Stat 1978, 6(2):461-464.
52. Rowen D, Young T, Brazier J, Gaugris S. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer. Value Health 2012, 15(8):1059-1068. Epub 2012/12/19, 10.1016/j.jval.2012.08.2201, 23244808.